On this 14 juillet and Bastille Day, we're celebrating our partnerships with French centers helping drive our research forward. France continues to play a leading role in our Rosalind Study. 39 oncology centers across France are contributing to the study, from major academic hospitals to regional cancer centers and community hospitals. Teams across the country are helping identify patients, collect clinical data and advance research.
New centers in our network
And our network keeps growing. We're happy to welcome seven new French centers from all regions to our network:
- CHU Nîmes
- Centre Antoine Lacassagne Nice
- CHU Clermont-Ferrand
- Institut Paoli-Calmettes Marseille (IPC)
- CHU Toulouse
- HCL Lyon
- CHU Dijon
Their participation strengthens an already remarkable national effort and brings us one step closer to unlocking the biology of exceptional cancer survivors. To every investigator, CRA, research coordinator and clinical team across France: merci.
Our French oncology network
Institut Gustave Roussy (IGR)
Centre Léon Bérard (CLB)
Sainte Catherine (ICAP) – Institut du Cancer Avignon-Provence
Hôpital Robert Schuman (Uneos)
Centre Georges-François Leclerc (CGFL Dijon)
Hôpital Saint-Antoine (AP-HP)
Hôpital Pitié-Salpêtrière (AP-HP)
Hôpital Paul-Brousse (AP-HP)
Hôpital Beaujon (AP-HP)
Hôpital Henri-Mondor (AP-HP)
Updated: July 14, 2026
